Glenmark repurchases bonds aggregating principal amount of US$ 75 million

15 Apr 2022 , 01:35 AM

On 7 April 2022 Glenmark Pharmaceuticals repurchased an aggregate principal amount of US$75000000 of the US$200000000 200 per cent Resettable Onward Starting Equity-linked Securities Due 2022 ISIN XS1426780125; Common Code 142678012 Bonds Repurchase The Repurchase was carried out by way of on-market purchases via The Hongkong and Shanghai Banking Corporation The Bonds are listed on the Singapore Exchange Securities Trading The settlement and cancellation for the repurchased Bonds had completed on 7 April 2022 Following cancellation the aggregate outstanding principal amount of the Bonds will be US$750000